No active studies recruiting at this time. Please check back.
COMPLETED STUDIES AWAITING PUBLICATION
ENROLLMENT CLOSED: AWAITING PUBLICATION
“The purpose of this research study is to know if the antibiotic azithromycin, an antibiotic approved by the U.S. Food and Drug Administration (FDA) for treating infections, improves symptom severity in children with sudden and severe onset obsessive compulsive symptoms known as PANS, Pediatric Acute Onset Neuropsychiatric Syndrome, and PANDAS, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus…” Clinical Trial Page Recruitment Summary
NIMH IVIG PANDAS STUDY
ENROLLMENT CLOSED : AWAITING PUBLICATION
“To test the safety and effectiveness of intravenous immunoglobulin for the treatment of obsessive-compulsive disorder in children with PANDAS (pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection).” Clinical Trial Page